Religare Research has come out with its first quarter (April-June) earnings estimates for the India Pharmaceuticals sector. The brokerage house expects Strides Shasun to report a degrowth of 8.9 percent quarter-on-quarter (up of 91.9 percent year-on-year) in net profit at Rs 87.6 crore.Sales are expected to decrease by 4.7 percent Q-o-Q (up 58.3 percent Y-o-Y) to Rs 955.0 crore, according to Religare Research.Earnings before interest, tax, depreciation and amortisation (EBITDA) are likely to fall by 5.3 percent Q-o-Q (up 111.9 percent Y-o-Y) to Rs 179.5 crore.Disclaimer: The views and investment tips expressed by investment experts on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
